Skip to main content
Equibles
ANIP $72.61 -1.55%
ANIP logo
ANIP · Ani Pharmaceuticals Inc
Track ANIP — free

Use ANIP with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ANIP.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$72.61 -1.14 (-1.55%) At close · Oct 23
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.67B
Shares
22.97M
Volume · Oct 23 318.61K Avg daily vol (3M) 382.32K
All webcasts

Earnings call · FY2019 Q4

Ani Pharmaceuticals Inc (ANIP) Q4 2019 Earnings Call

Concluded Feb 20, 2020
Feb 20, 2020 0 turns
Period
FY2019 Q4
Runtime
—
Sources
2 artifacts
Revenue $47.97M -16% YoY
Diluted EPS -$0.41 -189.1% YoY
Gross margin · derived Q4 62.9% -1.9 pp YoY
Net income -$4.83M -189% YoY
Open full screen 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Feb 20, 2020 10-K report Filed Feb 27, 2020
Full-screen source Call document

ANIP alerts

Ani Pharmaceuticals Inc

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →